FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

32975811000001102: Trifluridine 20mg / Tipiracil 8.19mg tablets 20 tablet (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 17-Aug 2016. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
100467901000001113 Trifluridine 20mg / Tipiracil 8.19mg tablets 20 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
100468001000001110 Trifluridine 20mg / Tipiracil 8.19mg tablets 20 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


1 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Trifluridine 20mg / Tipiracil 8.19mg tablets 20 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Trifluridine 20mg / Tipiracil 8.19mg tablets 20 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Trifluridine 20mg / Tipiracil 8.19mg tablets 20 tablet Has VMP Trifluridine 20mg / Tipiracil 8.19mg tablets true Inferred relationship Existential restriction modifier
Trifluridine 20mg / Tipiracil 8.19mg tablets 20 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Trifluridine 20mg / Tipiracil 8.19mg tablets 20 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Trifluridine 20mg / Tipiracil 8.19mg tablets 20 tablet Has specific active ingredient Tipiracil hydrochloride false Inferred relationship Existential restriction modifier
Trifluridine 20mg / Tipiracil 8.19mg tablets 20 tablet Has specific active ingredient Trifluridine true Inferred relationship Existential restriction modifier
Trifluridine 20mg / Tipiracil 8.19mg tablets 20 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Trifluridine 20mg / Tipiracil 8.19mg tablets 20 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Tipiracil false Inferred relationship Existential restriction modifier
Trifluridine 20mg / Tipiracil 8.19mg tablets 20 tablet Has specific active ingredient Tipiracil hydrochloride true Inferred relationship Existential restriction modifier
Trifluridine 20mg / Tipiracil 8.19mg tablets 20 tablet Has basis of strength substance Tipiracil true Inferred relationship Existential restriction modifier
Trifluridine 20mg / Tipiracil 8.19mg tablets 20 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Tipiracil true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Lonsurf 20mg/8.19mg tablets (Servier Laboratories Ltd) 20 tablet 2 x 10 tablets Is a True Trifluridine 20mg / Tipiracil 8.19mg tablets 20 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start